These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35197396)

  • 41. Pathogenicity and teratogenicity of Schmallenberg virus and Akabane virus in experimentally infected chicken embryos.
    Collins ÁB; Mee JF; Kirkland PD
    Vet Microbiol; 2018 Mar; 216():31-37. PubMed ID: 29519522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and pathogenic characterization of Akabane viruses isolated from cattle with encephalomyelitis in Korea.
    Oem JK; Yoon HJ; Kim HR; Roh IS; Lee KH; Lee OS; Bae YC
    Vet Microbiol; 2012 Aug; 158(3-4):259-66. PubMed ID: 22464491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence of Schmallenberg virus circulation in ruminants in Greece.
    Chaintoutis SC; Kiossis E; Giadinis ND; Brozos CN; Sailleau C; Viarouge C; Bréard E; Papanastassopoulou M; Zientara S; Papadopoulos O; Dovas CI
    Trop Anim Health Prod; 2014 Jan; 46(1):251-5. PubMed ID: 23868549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of recombinant Schmallenberg virus nucleocapsid protein in yeast and development of virus-specific monoclonal antibodies.
    Lazutka J; Zvirbliene A; Dalgediene I; Petraityte-Burneikiene R; Spakova A; Sereika V; Lelesius R; Wernike K; Beer M; Sasnauskas K
    J Immunol Res; 2014; 2014():160316. PubMed ID: 24982920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA vaccination regimes against Schmallenberg virus infection in IFNAR
    Boshra HY; Charro D; Lorenzo G; Sánchez I; Lazaro B; Brun A; Abrescia NG
    Antiviral Res; 2017 May; 141():107-115. PubMed ID: 28235558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a recombinant Akabane mutant virus with knockout of a nonstructural protein NSs in a pregnant goat model.
    Takenaka-Uema A; Bangphoomi N; Shioda C; Uchida K; Gen F; Kato K; Haga T; Murakami S; Akashi H; Hoimoto T
    Virol Sin; 2016 Jun; 31(3):274-7. PubMed ID: 27068656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orthobunyavirus spike architecture and recognition by neutralizing antibodies.
    Hellert J; Aebischer A; Wernike K; Haouz A; Brocchi E; Reiche S; Guardado-Calvo P; Beer M; Rey FA
    Nat Commun; 2019 Feb; 10(1):879. PubMed ID: 30787296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.
    Ruwona TB; Giang E; Nieusma T; Law M
    J Virol; 2014 Sep; 88(18):10459-71. PubMed ID: 24965471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and purification of the nucleocapsid protein of Schmallenberg virus, and preparation and characterization of a monoclonal antibody against this protein.
    Zhang Y; Wu S; Wang J; Wernike K; Lv J; Feng C; Zhang J; Wang C; Deng J; Yuan X; Lin X
    Protein Expr Purif; 2013 Nov; 92(1):1-8. PubMed ID: 23988909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.
    Tsai WY; Chen HL; Tsai JJ; Dejnirattisai W; Jumnainsong A; Mongkolsapaya J; Screaton G; Crowe JE; Wang WK
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30185598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.
    Babas T; Le Grand R; Dormont D; Bahraoui E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1109-19. PubMed ID: 9282816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an improved reverse genetics system for Akabane bunyavirus.
    Takenaka-Uema A; Sugiura K; Bangphoomi N; Shioda C; Uchida K; Kato K; Haga T; Murakami S; Akashi H; Horimoto T
    J Virol Methods; 2016 Jun; 232():16-20. PubMed ID: 26927704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
    Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
    J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The amino terminal subdomain of glycoprotein Gc of Schmallenberg virus: disulfide bonding and structural determinants of neutralization.
    Roman-Sosa G; Karger A; Kraatz F; Aebischer A; Wernike K; Maksimov P; Lillig CH; Reimann I; Brocchi E; Keller M; Beer M
    J Gen Virol; 2017 Jun; 98(6):1259-1273. PubMed ID: 28640745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.
    Lundkvist A; Niklasson B
    Arch Virol; 1992; 126(1-4):93-105. PubMed ID: 1381914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
    Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralizing antibodies against Simbu serogroup viruses in cattle and sheep, Nigeria, 2012-2014.
    Oluwayelu D; Wernike K; Adebiyi A; Cadmus S; Beer M
    BMC Vet Res; 2018 Sep; 14(1):277. PubMed ID: 30200958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
    Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.
    Kropff B; Burkhardt C; Schott J; Nentwich J; Fisch T; Britt W; Mach M
    PLoS Pathog; 2012; 8(10):e1002999. PubMed ID: 23133379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.